Nektar Therapeutics | NKTR - Market Capitalization


Nektar Therapeutics reported $12.74B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
ALKERMES USD 5.88B 1.26B Mar/2026
Alterity Therapeutics Limited AUD 47M 9M Jul/2026
Amgen USD 189.89B 13.64B Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cipla INR 1.13T 57.19B Jul/2026
Dr.Reddys Laboratories INR 982.96B 147.49B Jul/2026
Eisai JPY 1.42T 110.62B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Exelixis USD 10.89B 857M Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Incyte USD 18.73B 660M Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 1.12B 989M Jul/2026
MacroGenics USD 287M 103M Jul/2026
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 12.82B 11.96B Jul/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
Novartis USD 257.14B 50.62B Jul/2026
Pfizer USD 153.81B 12.24B Mar/2026
Roche Holding CHF 235.82B 34.18B Jul/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Takeda JPY 9.01T 1.37T Mar/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Xencor USD 893M 200M Mar/2026